Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ariyoshi

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Journal of Medical Virology|May 1, 1994
Development of a rapid quantitative assay for HIV-1 plasma infectious viraemia-culture-PCR (CPID)K Ariyoshi, S Bloor, P D Bieniasz, et al.
Journal of Human Virology|April 9, 1999
Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infectionN Berry, K Ariyoshi, S Jaffar, et al.
Japanese Journal of Clinical Oncology|May 26, 1999
Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphomaT Yamada, K Shinohara, K Takeda, et al.
Biological & Pharmaceutical Bulletin|May 1, 1993
An approach for assaying benzodiazepine receptor binding with radioiodinated ligand: 125I-labeled diazepam derivativeH Saji, Y Iida, K Ariyoshi, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1992
Mouse-human chimeric antibody MH171 against the multidrug transporter P-glycoproteinK Ariyoshi, H Hamada, M Naito, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1992
Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoproteinY Nishioka, S Sone, Y Heike, et al.
The Journal of Biological Chemistry|May 24, 2000
Constitutive activation of STAT5 by a point mutation in the SH2 domainK Ariyoshi, T Nosaka, K Yamada, et al.
AIDS (London, England)|June 1, 1995
HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral loadK Ariyoshi, F Cham, N Berry, et al.
AIDS (London, England)|July 1, 1997
Does HIV-2 infection provide cross-protection against HIV-1 infection?K Ariyoshi, M Schim van der Loeff, S Sabally, et al.
AIDS (London, England)|April 19, 2000
Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIVD O'Donovan, K Ariyoshi, P Milligan, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Journal of Medical Virology|May 1, 1994
Development of a rapid quantitative assay for HIV-1 plasma infectious viraemia-culture-PCR (CPID)K Ariyoshi, S Bloor, P D Bieniasz, et al.
Journal of Human Virology|April 9, 1999
Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infectionN Berry, K Ariyoshi, S Jaffar, et al.
Japanese Journal of Clinical Oncology|May 26, 1999
Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphomaT Yamada, K Shinohara, K Takeda, et al.
Biological & Pharmaceutical Bulletin|May 1, 1993
An approach for assaying benzodiazepine receptor binding with radioiodinated ligand: 125I-labeled diazepam derivativeH Saji, Y Iida, K Ariyoshi, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1992
Mouse-human chimeric antibody MH171 against the multidrug transporter P-glycoproteinK Ariyoshi, H Hamada, M Naito, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1992
Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoproteinY Nishioka, S Sone, Y Heike, et al.
The Journal of Biological Chemistry|May 24, 2000
Constitutive activation of STAT5 by a point mutation in the SH2 domainK Ariyoshi, T Nosaka, K Yamada, et al.
AIDS (London, England)|June 1, 1995
HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral loadK Ariyoshi, F Cham, N Berry, et al.
AIDS (London, England)|July 1, 1997
Does HIV-2 infection provide cross-protection against HIV-1 infection?K Ariyoshi, M Schim van der Loeff, S Sabally, et al.
AIDS (London, England)|April 19, 2000
Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIVD O'Donovan, K Ariyoshi, P Milligan, et al.
Pageof 10